{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T02:22:48Z","timestamp":1781835768663,"version":"3.54.5"},"reference-count":111,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100003995","name":"Natural Science Foundation of Anhui Province","doi-asserted-by":"publisher","award":["2008085QH412"],"award-info":[{"award-number":["2008085QH412"]}],"id":[{"id":"10.13039\/501100003995","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003995","name":"Natural Science Foundation of Anhui Province","doi-asserted-by":"publisher","award":["XJ201943"],"award-info":[{"award-number":["XJ201943"]}],"id":[{"id":"10.13039\/501100003995","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004608","name":"Natural Science Foundation of Jiangsu Province","doi-asserted-by":"publisher","award":["2019xkj018"],"award-info":[{"award-number":["2019xkj018"]}],"id":[{"id":"10.13039\/501100004608","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002947","name":"Anhui Medical University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002947","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Immunopharmacology"],"published-print":{"date-parts":[[2023,5]]},"DOI":"10.1016\/j.intimp.2023.110128","type":"journal-article","created":{"date-parts":[[2023,4,4]],"date-time":"2023-04-04T07:40:27Z","timestamp":1680594027000},"page":"110128","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"special_numbering":"C","title":["RIPK2 as a promising druggable target for autoimmune diseases"],"prefix":"10.1016","volume":"118","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6589-1826","authenticated-orcid":false,"given":"Wei","family":"Zhao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui-Xue","family":"Leng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dong-Qing","family":"Ye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.intimp.2023.110128_b0005","unstructured":"Johns Hopkins Pathology. Definition of Autoimmunity & Autoimmune Disease [cited 2023]. Available from: https:\/\/pathology.jhu.edu\/autoimmune\/definitions."},{"issue":"3","key":"10.1016\/j.intimp.2023.110128_b0010","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/j.yfrne.2014.04.004","article-title":"Gender differences in autoimmune disease","volume":"35","author":"Ngo","year":"2014","journal-title":"Front. Neuroendocrinol."},{"issue":"4","key":"10.1016\/j.intimp.2023.110128_b0015","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1111\/joim.12395","article-title":"Human autoimmune diseases: a comprehensive update","volume":"278","author":"Wang","year":"2015","journal-title":"J. Intern. Med."},{"key":"10.1016\/j.intimp.2023.110128_b0020","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaut.2019.102315","article-title":"Epigenetic perspectives on systemic autoimmune disease","volume":"104","author":"Karagianni","year":"2019","journal-title":"J. Autoimmun."},{"issue":"5","key":"10.1016\/j.intimp.2023.110128_b0025","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1093\/aje\/kwv292","article-title":"Prediction and Prevention of Autoimmune Disease in the 21st Century: A Review and Preview","volume":"183","author":"Rose","year":"2016","journal-title":"Am. J. Epidemiol."},{"key":"10.1016\/j.intimp.2023.110128_b0030","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.semcdb.2020.06.014","article-title":"RIPK protein kinase family: Atypical lives of typical kinases","volume":"109","author":"Cuny","year":"2021","journal-title":"Semin. Cell Dev. Biol."},{"issue":"20","key":"10.1016\/j.intimp.2023.110128_b0035","doi-asserted-by":"crossref","first-page":"12296","DOI":"10.1074\/jbc.273.20.12296","article-title":"RICK, a novel protein kinase containing a caspase recruitment domain, interacts with CLARP and regulates CD95-mediated apoptosis","volume":"273","author":"Inohara","year":"1998","journal-title":"J. Biol. Chem."},{"issue":"27","key":"10.1016\/j.intimp.2023.110128_b0040","doi-asserted-by":"crossref","first-page":"16968","DOI":"10.1074\/jbc.273.27.16968","article-title":"RIP2 is a novel NF-kappaB-activating and cell death-inducing kinase","volume":"273","author":"McCarthy","year":"1998","journal-title":"J. Biol. Chem."},{"issue":"15","key":"10.1016\/j.intimp.2023.110128_b0045","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1016\/S0960-9822(07)00352-1","article-title":"Identification of CARDIAK, a RIP-like kinase that associates with caspase-1","volume":"8","author":"Thome","year":"1998","journal-title":"Curr. Biol."},{"key":"10.1016\/j.intimp.2023.110128_b0050","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2021.650403","article-title":"RIPK2 as a New Therapeutic Target in Inflammatory Bowel Diseases","volume":"12","author":"Honjo","year":"2021","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.intimp.2023.110128_b0055","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.semcdb.2020.07.001","article-title":"RIPK2 NODs to XIAP and IBD","volume":"109","author":"Topal","year":"2021","journal-title":"Semin. Cell Dev. Biol."},{"issue":"9","key":"10.1016\/j.intimp.2023.110128_b0060","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1038\/s41590-018-0188-x","article-title":"RIP kinases as modulators of inflammation and immunity","volume":"19","author":"He","year":"2018","journal-title":"Nat. Immunol."},{"issue":"3","key":"10.1016\/j.intimp.2023.110128_b0065","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.tibs.2005.01.003","article-title":"The RIP kinases: crucial integrators of cellular stress","volume":"30","author":"Meylan","year":"2005","journal-title":"Trends Biochem. Sci"},{"issue":"7","key":"10.1016\/j.intimp.2023.110128_b0070","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1038\/cdd.2017.33","article-title":"Diverse ubiquitin linkages regulate RIP kinases-mediated inflammatory and cell death signaling","volume":"24","author":"Witt","year":"2017","journal-title":"Cell Death Differ."},{"issue":"2","key":"10.1016\/j.intimp.2023.110128_b0075","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1038\/sj.emboj.7601962","article-title":"A critical role of RICK\/RIP2 polyubiquitination in Nod-induced NF-kappaB activation","volume":"27","author":"Hasegawa","year":"2008","journal-title":"EMBO J."},{"issue":"4","key":"10.1016\/j.intimp.2023.110128_b0080","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1038\/cmi.2010.10","article-title":"Receptor-interacting protein (RIP) kinase family","volume":"7","author":"Zhang","year":"2010","journal-title":"Cell. Mol. Immunol."},{"issue":"12","key":"10.1016\/j.intimp.2023.110128_b0085","doi-asserted-by":"crossref","first-page":"2223","DOI":"10.1016\/j.cellsig.2006.05.005","article-title":"Identification of a regulatory autophosphorylation site in the serine-threonine kinase RIP2","volume":"18","author":"Dorsch","year":"2006","journal-title":"Cell. Signal."},{"key":"10.1016\/j.intimp.2023.110128_b0090","article-title":"ATG16L1 negatively regulates RICK\/RIP2-mediated innate immune responses","author":"Honjo","year":"2020","journal-title":"Int. Immunol."},{"issue":"6","key":"10.1016\/j.intimp.2023.110128_b0095","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.1038\/mi.2014.19","article-title":"NOD2 downregulates colonic inflammation by IRF4-mediated inhibition of K63-linked polyubiquitination of RICK and TRAF6","volume":"7","author":"Watanabe","year":"2014","journal-title":"Mucosal Immunol."},{"key":"10.1016\/j.intimp.2023.110128_b0100","doi-asserted-by":"crossref","first-page":"208","DOI":"10.3389\/fcell.2019.00208","article-title":"NOD Signaling and Cell Death","volume":"7","author":"Heim","year":"2019","journal-title":"Front. Cell Dev. Biol."},{"issue":"20","key":"10.1016\/j.intimp.2023.110128_b0105","doi-asserted-by":"crossref","first-page":"6310","DOI":"10.1021\/bi0340752","article-title":"Equilibrium and kinetic folding of an alpha-helical Greek key protein domain: caspase recruitment domain (CARD) of RICK","volume":"42","author":"Chen","year":"2003","journal-title":"Biochemistry"},{"issue":"1","key":"10.1016\/j.intimp.2023.110128_b0110","doi-asserted-by":"crossref","first-page":"4993","DOI":"10.1038\/s41467-018-07447-9","article-title":"Structural basis of RIP2 activation and signaling","volume":"9","author":"Gong","year":"2018","journal-title":"Nat. Commun."},{"issue":"23","key":"10.1016\/j.intimp.2023.110128_b0115","doi-asserted-by":"crossref","first-page":"2666","DOI":"10.1101\/gad.1964410","article-title":"Inhibition of RIP2's tyrosine kinase activity limits NOD2-driven cytokine responses","volume":"24","author":"Tigno-Aranjuez","year":"2010","journal-title":"Genes Dev."},{"issue":"1","key":"10.1016\/j.intimp.2023.110128_b0120","doi-asserted-by":"crossref","first-page":"4043","DOI":"10.1038\/s41467-018-06451-3","article-title":"RIP2 filament formation is required for NOD2 dependent NF-\u03baB signalling","volume":"9","author":"Pellegrini","year":"2018","journal-title":"Nat. Commun."},{"key":"10.1016\/j.intimp.2023.110128_b0125","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1034\/j.1600-065X.2000.917309.x","article-title":"Innate immune recognition: mechanisms and pathways","volume":"173","author":"Medzhitov","year":"2000","journal-title":"Immunol. Rev."},{"issue":"5","key":"10.1016\/j.intimp.2023.110128_b0130","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1002\/eji.201040827","article-title":"Essential role of Rip2 in the modulation of innate and adaptive immunity triggered by Nod1 and Nod2 ligands","volume":"41","author":"Magalhaes","year":"2011","journal-title":"Eur. J. Immunol."},{"issue":"2","key":"10.1016\/j.intimp.2023.110128_b0135","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1111\/imm.12307","article-title":"Nod2 and Rip2 contribute to innate immune responses in mouse neutrophils","volume":"143","author":"Jeong","year":"2014","journal-title":"Immunology"},{"issue":"6","key":"10.1016\/j.intimp.2023.110128_b0140","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1016\/j.cell.2010.01.022","article-title":"Pattern recognition receptors and inflammation","volume":"140","author":"Takeuchi","year":"2010","journal-title":"Cell"},{"issue":"670","key":"10.1016\/j.intimp.2023.110128_b0145","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.abb.2018.12.022","article-title":"NOD1 and NOD2 in inflammation, immunity and disease","volume":"30","author":"Mukherjee","year":"2019","journal-title":"Arch. Biochem. Biophys."},{"issue":"11","key":"10.1016\/j.intimp.2023.110128_b0150","doi-asserted-by":"crossref","first-page":"1742","DOI":"10.1038\/s41401-020-00603-2","article-title":"NOD-like receptors in autoimmune diseases","volume":"42","author":"Chen","year":"2021","journal-title":"Acta Pharmacol. Sin."},{"issue":"1","key":"10.1016\/j.intimp.2023.110128_b0155","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1038\/nri3565","article-title":"NOD proteins: regulators of inflammation in health and disease","volume":"14","author":"Philpott","year":"2014","journal-title":"Nat. Rev. Immunol."},{"issue":"5","key":"10.1016\/j.intimp.2023.110128_b0160","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1016\/j.immuni.2013.10.013","article-title":"The protein ATG16L1 suppresses inflammatory cytokines induced by the intracellular sensors Nod1 and Nod2 in an autophagy-independent manner","volume":"39","author":"Sorbara","year":"2013","journal-title":"Immunity"},{"key":"10.1016\/j.intimp.2023.110128_b0165","doi-asserted-by":"crossref","DOI":"10.1016\/j.cellsig.2022.110283","article-title":"METTL3 regulates LPS-induced inflammatory response via the NOD1 signaling pathway","volume":"93","author":"Cai","year":"2022","journal-title":"Cell. Signal."},{"issue":"6877","key":"10.1016\/j.intimp.2023.110128_b0170","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1038\/416190a","article-title":"Involvement of receptor-interacting protein 2 in innate and adaptive immune responses","volume":"416","author":"Chin","year":"2002","journal-title":"Nature"},{"issue":"6877","key":"10.1016\/j.intimp.2023.110128_b0175","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1038\/416194a","article-title":"RICK\/Rip2\/CARDIAK mediates signalling for receptors of the innate and adaptive immune systems","volume":"416","author":"Kobayashi","year":"2002","journal-title":"Nature"},{"issue":"16","key":"10.1016\/j.intimp.2023.110128_b0180","doi-asserted-by":"crossref","first-page":"16278","DOI":"10.1074\/jbc.M410114200","article-title":"Participation of Rip2 in lipopolysaccharide signaling is independent of its kinase activity","volume":"280","author":"Lu","year":"2005","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.intimp.2023.110128_b0185","doi-asserted-by":"crossref","unstructured":"Park JH, Kim YG, McDonald C, et al. RICK\/RIP2 mediates innate immune responses induced through Nod1 and Nod2 but not TLRs. Journal of immunology (Baltimore, Md : 1950). 2007 Feb 15;178(4):2380-6.","DOI":"10.4049\/jimmunol.178.4.2380"},{"issue":"1","key":"10.1016\/j.intimp.2023.110128_b0190","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1002\/eji.200737393","article-title":"RIP2 contributes to Nod signaling but is not essential for T cell proliferation, T helper differentiation or TLR responses","volume":"38","author":"Hall","year":"2008","journal-title":"Eur. J. Immunol."},{"issue":"4","key":"10.1016\/j.intimp.2023.110128_b0195","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1038\/cr.2016.40","article-title":"Ubiquitin signaling in immune responses","volume":"26","author":"Hu","year":"2016","journal-title":"Cell Res."},{"issue":"8","key":"10.1016\/j.intimp.2023.110128_b0200","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a036426","article-title":"Regulation of Cell Death and Immunity by XIAP","volume":"12","author":"Jost","year":"2020","journal-title":"Cold Spring Harb. Perspect. Biol."},{"issue":"34","key":"10.1016\/j.intimp.2023.110128_b0205","doi-asserted-by":"crossref","first-page":"14524","DOI":"10.1073\/pnas.0907131106","article-title":"XIAP mediates NOD signaling via interaction with RIP2","volume":"106","author":"Krieg","year":"2009","journal-title":"PNAS"},{"issue":"6","key":"10.1016\/j.intimp.2023.110128_b0210","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1016\/j.molcel.2012.04.014","article-title":"The ubiquitin ligase XIAP recruits LUBAC for NOD2 signaling in inflammation and innate immunity","volume":"46","author":"Damgaard","year":"2012","journal-title":"Mol. Cell"},{"issue":"4","key":"10.1016\/j.intimp.2023.110128_b0215","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1016\/j.molcel.2018.01.016","article-title":"Disruption of XIAP-RIP2 Association Blocks NOD2-Mediated Inflammatory Signaling","volume":"69","author":"Goncharov","year":"2018","journal-title":"Mol. Cell"},{"issue":"17","key":"10.1016\/j.intimp.2023.110128_b0220","doi-asserted-by":"crossref","DOI":"10.15252\/embj.201899372","article-title":"Small molecule inhibitors reveal an indispensable scaffolding role of RIPK2 in NOD2 signaling","volume":"37","author":"Hrdinka","year":"2018","journal-title":"EMBO J."},{"issue":"6","key":"10.1016\/j.intimp.2023.110128_b0225","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1016\/j.immuni.2009.04.011","article-title":"Cellular inhibitors of apoptosis cIAP1 and cIAP2 are required for innate immunity signaling by the pattern recognition receptors NOD1 and NOD2","volume":"30","author":"Bertrand","year":"2009","journal-title":"Immunity"},{"issue":"50","key":"10.1016\/j.intimp.2023.110128_b0230","doi-asserted-by":"crossref","first-page":"36223","DOI":"10.1074\/jbc.M703079200","article-title":"NOD2 pathway activation by MDP or Mycobacterium tuberculosis infection involves the stable polyubiquitination of Rip2","volume":"282","author":"Yang","year":"2007","journal-title":"J. Biol. Chem."},{"issue":"9","key":"10.1016\/j.intimp.2023.110128_b0235","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1038\/ni.2669","article-title":"Pellino3 ubiquitinates RIP2 and mediates Nod2-induced signaling and protective effects in colitis","volume":"14","author":"Yang","year":"2013","journal-title":"Nat. Immunol."},{"issue":"15","key":"10.1016\/j.intimp.2023.110128_b0240","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1016\/j.cub.2009.06.038","article-title":"ITCH K63-ubiquitinates the NOD2 binding protein, RIP2, to influence inflammatory signaling pathways","volume":"19","author":"Tao","year":"2009","journal-title":"Curr. Biol."},{"issue":"32","key":"10.1016\/j.intimp.2023.110128_b0245","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2013500118","article-title":"The E3 ubiquitin ligase RNF186 and RNF186 risk variants regulate innate receptor-induced outcomes","volume":"118","author":"Ranjan","year":"2021","journal-title":"PNAS"},{"issue":"3","key":"10.1016\/j.intimp.2023.110128_b0250","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/j.immuni.2008.02.002","article-title":"The ubiquitin-editing enzyme A20 restricts nucleotide-binding oligomerization domain containing 2-triggered signals","volume":"28","author":"Hitotsumatsu","year":"2008","journal-title":"Immunity"},{"issue":"8","key":"10.1016\/j.intimp.2023.110128_b0255","doi-asserted-by":"crossref","first-page":"15865","DOI":"10.1038\/ncomms15865","article-title":"E3 Ubiquitin ligase ZNRF4 negatively regulates NOD2 signalling and induces tolerance to MDP","volume":"28","author":"Bist","year":"2017","journal-title":"Nat. Commun."},{"issue":"6","key":"10.1016\/j.intimp.2023.110128_b0260","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1016\/j.molcel.2013.06.004","article-title":"OTULIN restricts Met1-linked ubiquitination to control innate immune signaling","volume":"50","author":"Fiil","year":"2013","journal-title":"Mol. Cell"},{"issue":"12","key":"10.1016\/j.intimp.2023.110128_b0265","doi-asserted-by":"crossref","first-page":"2846","DOI":"10.1016\/j.celrep.2016.02.062","article-title":"CYLD Limits Lys63- and Met1-Linked Ubiquitin at Receptor Complexes to Regulate Innate Immune Signaling","volume":"14","author":"Hrdinka","year":"2016","journal-title":"Cell Rep."},{"issue":"1","key":"10.1016\/j.intimp.2023.110128_b0270","doi-asserted-by":"crossref","first-page":"4654","DOI":"10.1038\/s41467-018-07016-0","article-title":"The deubiquitinase MYSM1 dampens NOD2-mediated inflammation and tissue damage by inactivating the RIP2 complex","volume":"9","author":"Panda","year":"2018","journal-title":"Nat. Commun."},{"issue":"7","key":"10.1016\/j.intimp.2023.110128_b0275","doi-asserted-by":"crossref","first-page":"e41255","DOI":"10.1371\/journal.pone.0041255","article-title":"TRIM27 negatively regulates NOD2 by ubiquitination and proteasomal degradation","volume":"7","author":"Zurek","year":"2012","journal-title":"PLoS One"},{"issue":"2 Suppl 2","key":"10.1016\/j.intimp.2023.110128_b0280","doi-asserted-by":"crossref","first-page":"S33","DOI":"10.1016\/j.jaci.2009.09.017","article-title":"Adaptive immunity","volume":"125","author":"Bonilla","year":"2010","journal-title":"J. Allergy Clin. Immunol."},{"issue":"2","key":"10.1016\/j.intimp.2023.110128_b0285","doi-asserted-by":"crossref","first-page":"1570","DOI":"10.1074\/jbc.C300460200","article-title":"Rip2 participates in Bcl10 signaling and T-cell receptor-mediated NF-kappaB activation","volume":"279","author":"Ruefli-Brasse","year":"2004","journal-title":"J. Biol. Chem."},{"issue":"5","key":"10.1016\/j.intimp.2023.110128_b0290","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1016\/j.immuni.2018.08.022","article-title":"T-Cell-Intrinsic Receptor Interacting Protein 2 Regulates Pathogenic T Helper 17 Cell Differentiation","volume":"49","author":"Shimada","year":"2018","journal-title":"Immunity"},{"issue":"6","key":"10.1016\/j.intimp.2023.110128_b0295","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1111\/j.1600-6143.2008.02236.x","article-title":"RIP2 is required for NOD signaling but not for Th1 cell differentiation and cellular allograft rejection","volume":"8","author":"Fairhead","year":"2008","journal-title":"Am. J. Transplant. Off. J. Am. Soc. Transplant. Am. Soc. Transplant Surg."},{"key":"10.1016\/j.intimp.2023.110128_b0300","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.3389\/fimmu.2019.01094","article-title":"Dysregulation of Intestinal Epithelial Cell RIPK Pathways Promotes Chronic Inflammation in the IBD Gut","volume":"10","author":"Garcia-Carbonell","year":"2019","journal-title":"Front. Immunol."},{"issue":"12","key":"10.1016\/j.intimp.2023.110128_b0305","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1038\/nrgastro.2015.150","article-title":"The global burden of IBD: from 2015 to 2025","volume":"12","author":"Kaplan","year":"2015","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"issue":"7422","key":"10.1016\/j.intimp.2023.110128_b0310","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1038\/nature11582","article-title":"Host-microbe interactions have shaped the genetic architecture of inflammatory bowel disease","volume":"491","author":"Jostins","year":"2012","journal-title":"Nature"},{"issue":"8","key":"10.1016\/j.intimp.2023.110128_b0315","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1002\/ibd.20907","article-title":"Activation of NOD2-mediated intestinal pathway in a pediatric population with Crohn's disease","volume":"15","author":"Negroni","year":"2009","journal-title":"Inflamm. Bowel Dis."},{"issue":"12","key":"10.1016\/j.intimp.2023.110128_b0320","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1016\/j.dld.2010.04.003","article-title":"Altered expression of innate immunity genes in different intestinal sites of children with ulcerative colitis","volume":"42","author":"Stronati","year":"2010","journal-title":"Digestive Liver Dis.: Off. J. Italian Soc. Gastroenterol. Italian Assoc. Study Liver."},{"issue":"10","key":"10.1016\/j.intimp.2023.110128_b0325","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1093\/intimm\/dxz045","article-title":"RICK\/RIP2 is a NOD2-independent nodal point of gut inflammation","volume":"31","author":"Watanabe","year":"2019","journal-title":"Int. Immunol."},{"issue":"25","key":"10.1016\/j.intimp.2023.110128_b0330","doi-asserted-by":"crossref","first-page":"E2559","DOI":"10.1073\/pnas.1408540111","article-title":"Nod\/Ripk2 signaling in dendritic cells activates IL-17A-secreting innate lymphoid cells and drives colitis in T-bet-\/-.Rag2-\/- (TRUC) mice","volume":"111","author":"Ermann","year":"2014","journal-title":"PNAS"},{"issue":"43","key":"10.1016\/j.intimp.2023.110128_b0335","doi-asserted-by":"crossref","first-page":"29651","DOI":"10.1074\/jbc.M114.591388","article-title":"In vivo inhibition of RIPK2 kinase alleviates inflammatory disease","volume":"289","author":"Tigno-Aranjuez","year":"2014","journal-title":"J. Biol. Chem."},{"issue":"15","key":"10.1016\/j.intimp.2023.110128_b0340","doi-asserted-by":"crossref","first-page":"14981","DOI":"10.1074\/jbc.M500966200","article-title":"Inhibition of RICK\/nuclear factor-kappaB and p38 signaling attenuates the inflammatory response in a murine model of Crohn disease","volume":"280","author":"Hollenbach","year":"2005","journal-title":"J. Biol. Chem."},{"issue":"5","key":"10.1016\/j.intimp.2023.110128_b0345","doi-asserted-by":"crossref","first-page":"G500","DOI":"10.1152\/ajpgi.00163.2021","article-title":"The potent and selective RIPK2 inhibitor BI 706039 improves intestinal inflammation in the TRUC mouse model of inflammatory bowel disease","volume":"321","author":"Ermann","year":"2021","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"issue":"6837","key":"10.1016\/j.intimp.2023.110128_b0350","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1038\/35079114","article-title":"A frameshift mutation in NOD2 associated with susceptibility to Crohn's disease","volume":"411","author":"Ogura","year":"2001","journal-title":"Nature"},{"issue":"6837","key":"10.1016\/j.intimp.2023.110128_b0355","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1038\/35079107","article-title":"Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease","volume":"411","author":"Hugot","year":"2001","journal-title":"Nature"},{"key":"10.1016\/j.intimp.2023.110128_b0360","first-page":"1","article-title":"The Crohn Disease-associated ATG16L1(T300A) polymorphism regulates inflammatory responses by modulating TLR- and NLR-mediated signaling","volume":"27","author":"Gao","year":"2022","journal-title":"Autophagy"},{"issue":"5","key":"10.1016\/j.intimp.2023.110128_b0365","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1038\/mi.2011.29","article-title":"NOD2, an intracellular innate immune sensor involved in host defense and Crohn's disease","volume":"4","author":"Strober","year":"2011","journal-title":"Mucosal Immunol."},{"issue":"8","key":"10.1016\/j.intimp.2023.110128_b0370","doi-asserted-by":"crossref","first-page":"1278","DOI":"10.1002\/emmm.201303090","article-title":"Disease-causing mutations in the XIAP BIR2 domain impair NOD2-dependent immune signalling","volume":"5","author":"Damgaard","year":"2013","journal-title":"EMBO Mol. Med."},{"key":"10.1016\/j.intimp.2023.110128_b0375","doi-asserted-by":"crossref","unstructured":"Sparks JA. Rheumatoid Arthritis. Annals of internal medicine. 2019 Jan 1;170(1):Itc1-itc16.","DOI":"10.7326\/AITC201901010"},{"issue":"5","key":"10.1016\/j.intimp.2023.110128_b0380","doi-asserted-by":"crossref","DOI":"10.1016\/j.berh.2019.101477","article-title":"The epidemiology of established rheumatoid arthritis","volume":"33","author":"Ot\u00f3n","year":"2019","journal-title":"Best Pract. Res. Clin. Rheumatol."},{"issue":"12","key":"10.1016\/j.intimp.2023.110128_b0385","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1136\/annrheumdis-2020-217351","article-title":"Identification of new susceptibility loci associated with rheumatoid arthritis","volume":"79","author":"Leng","year":"2020","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.intimp.2023.110128_b0390","unstructured":"Kim HW, Kwon YJ, Park BW, et al. Differential expressions of NOD-like receptors and their associations with inflammatory responses in rheumatoid arthritis. Clinical and experimental rheumatology. 2017 Jul-Aug;35(4):630-637."},{"issue":"1","key":"10.1016\/j.intimp.2023.110128_b0395","doi-asserted-by":"crossref","first-page":"8","DOI":"10.3109\/03009742.2015.1047403","article-title":"Expression and activity of NOD1 and NOD2\/RIPK2 signalling in mononuclear cells from patients with rheumatoid arthritis","volume":"45","author":"Franca","year":"2016","journal-title":"Scand. J. Rheumatol."},{"key":"10.1016\/j.intimp.2023.110128_b0400","doi-asserted-by":"crossref","unstructured":"Vieira SM, Cunha TM, Fran\u00e7a RF, et al. Joint NOD2\/RIPK2 signaling regulates IL-17 axis and contributes to the development of experimental arthritis. Journal of immunology (Baltimore, Md : 1950). 2012 May 15;188(10):5116-22.","DOI":"10.4049\/jimmunol.1004190"},{"issue":"8","key":"10.1016\/j.intimp.2023.110128_b0405","first-page":"4650","article-title":"Downregulation of lncRNA ITSN1-2 correlates with decreased disease risk and activity of rheumatoid arthritis (RA), and reduces RA fibroblast-like synoviocytes proliferation and inflammation via inhibiting NOD2\/RIP2 signaling pathway","volume":"11","author":"Yue","year":"2019","journal-title":"Am. J. Transl. Res."},{"issue":"10130","key":"10.1016\/j.intimp.2023.110128_b0410","doi-asserted-by":"crossref","first-page":"1622","DOI":"10.1016\/S0140-6736(18)30481-1","article-title":"Multiple sclerosis","volume":"391","author":"Thompson","year":"2018","journal-title":"Lancet (London, England)."},{"key":"10.1016\/j.intimp.2023.110128_b0415","doi-asserted-by":"crossref","unstructured":"Global, regional, and national burden of multiple sclerosis 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016. The Lancet Neurology. 2019 Mar;18(3):269-285.","DOI":"10.1016\/S1474-4422(18)30443-5"},{"issue":"3","key":"10.1016\/j.intimp.2023.110128_b0420","first-page":"527","article-title":"Progressive multiple sclerosis: from pathogenic mechanisms to treatment","volume":"140","author":"Correale","year":"2017","journal-title":"Brain J. Neurol."},{"issue":"1","key":"10.1016\/j.intimp.2023.110128_b0425","doi-asserted-by":"crossref","first-page":"9171","DOI":"10.1038\/s41598-019-45598-x","article-title":"Multiple Sclerosis patients carry an increased burden of exceedingly rare genetic variants in the inflammasome regulatory genes","volume":"9","author":"Vidmar","year":"2019","journal-title":"Sci. Rep."},{"issue":"3","key":"10.1016\/j.intimp.2023.110128_b0430","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/j.nbd.2004.10.007","article-title":"Microarray analysis identifies an aberrant expression of apoptosis and DNA damage-regulatory genes in multiple sclerosis","volume":"18","author":"Satoh","year":"2005","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.intimp.2023.110128_b0435","doi-asserted-by":"crossref","unstructured":"Glatigny S, Bettelli E. Experimental Autoimmune Encephalomyelitis (EAE) as Animal Models of Multiple Sclerosis (MS). Cold Spring Harbor perspectives in medicine. 2018 Nov 1;8(11).","DOI":"10.1101\/cshperspect.a028977"},{"issue":"6","key":"10.1016\/j.intimp.2023.110128_b0440","doi-asserted-by":"crossref","first-page":"6442","DOI":"10.1038\/ncomms7442","article-title":"A RIPK2 inhibitor delays NOD signalling events yet prevents inflammatory cytokine production","volume":"17","author":"Nachbur","year":"2015","journal-title":"Nat. Commun."},{"issue":"1","key":"10.1016\/j.intimp.2023.110128_b0445","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.immuni.2010.12.015","article-title":"Signaling via the RIP2 adaptor protein in central nervous system-infiltrating dendritic cells promotes inflammation and autoimmunity","volume":"34","author":"Shaw","year":"2011","journal-title":"Immunity"},{"key":"10.1016\/j.intimp.2023.110128_b0450","doi-asserted-by":"crossref","unstructured":"Kiriakidou M, Ching CL. Systemic Lupus Erythematosus. Annals of internal medicine. 2020 Jun 2;172(11):Itc81-itc96.","DOI":"10.7326\/AITC202006020"},{"issue":"11","key":"10.1016\/j.intimp.2023.110128_b0455","doi-asserted-by":"crossref","first-page":"1945","DOI":"10.1093\/rheumatology\/kex260","article-title":"The worldwide incidence and prevalence of systemic lupus erythematosus: a systematic review of epidemiological studies","volume":"56","author":"Rees","year":"2017","journal-title":"Rheumatology (Oxford)"},{"issue":"12","key":"10.1016\/j.intimp.2023.110128_b0460","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1038\/nrrheum.2016.186","article-title":"New insights into the immunopathogenesis of systemic lupus erythematosus","volume":"12","author":"Tsokos","year":"2016","journal-title":"Nat. Rev. Rheumatol."},{"issue":"3","key":"10.1016\/j.intimp.2023.110128_b0465","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1093\/mutage\/ger081","article-title":"Association of RIP2 gene polymorphisms and systemic lupus erythematosus in a Chinese population","volume":"27","author":"Li","year":"2012","journal-title":"Mutagenesis"},{"key":"10.1016\/j.intimp.2023.110128_b0470","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.3389\/fimmu.2020.01027","article-title":"T Cell Metabolism: A New Perspective on Th17\/Treg Cell Imbalance in Systemic Lupus Erythematosus","volume":"11","author":"Shan","year":"2020","journal-title":"Front. Immunol."},{"key":"10.1016\/j.intimp.2023.110128_b0475","doi-asserted-by":"crossref","DOI":"10.1007\/s10753-018-0815-6","article-title":"RNAi Silencing of HIF-1alpha Ameliorates Lupus Development in MRL\/lpr Mice","author":"Zhao","year":"2018","journal-title":"Inflammation"},{"issue":"6","key":"10.1016\/j.intimp.2023.110128_b0480","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1016\/j.autrev.2017.12.006","article-title":"Beh\u00e7et's disease: New insights into pathophysiology, clinical features and treatment options","volume":"17","author":"Greco","year":"2018","journal-title":"Autoimmun. Rev."},{"issue":"1","key":"10.1016\/j.intimp.2023.110128_b0485","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1080\/1744666X.2016.1205486","article-title":"Behcet's disease: epidemiology, clinical manifestations, and diagnosis","volume":"13","author":"Davatchi","year":"2017","journal-title":"Expert Rev. Clin. Immunol."},{"key":"10.1016\/j.intimp.2023.110128_b0490","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.3389\/fimmu.2019.01067","article-title":"Beh\u00e7et's Disease: An Overview of Etiopathogenesis","volume":"10","author":"Leccese","year":"2019","journal-title":"Front. Immunol."},{"issue":"3","key":"10.1016\/j.intimp.2023.110128_b0495","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1038\/ng.3786","article-title":"Dense genotyping of immune-related loci implicates host responses to microbial exposure in Beh\u00e7et's disease susceptibility","volume":"49","author":"Takeuchi","year":"2017","journal-title":"Nat. Genet."},{"issue":"9","key":"10.1016\/j.intimp.2023.110128_b0500","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1136\/bjophthalmol-2017-311753","article-title":"Association of LACC1, CEBPB-PTPN1, RIPK2 and ADO-EGR2 with ocular Behcet's disease in a Chinese Han population","volume":"102","author":"Wu","year":"2018","journal-title":"Br. J. Ophthalmol."},{"issue":"1\u20132","key":"10.1016\/j.intimp.2023.110128_b0505","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1007\/s11010-005-3701-0","article-title":"Inhibition of RIP2\/RIck\/CARDIAK activity by pyridinyl imidazole inhibitors of p38 MAPK","volume":"268","author":"Argast","year":"2005","journal-title":"Mol. Cell. Biochem."},{"issue":"9","key":"10.1016\/j.intimp.2023.110128_b0510","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1016\/j.chembiol.2015.07.017","article-title":"Inflammatory Signaling by NOD-RIPK2 Is Inhibited by Clinically Relevant Type II Kinase Inhibitors","volume":"22","author":"Canning","year":"2015","journal-title":"Chem. Biol."},{"issue":"10","key":"10.1016\/j.intimp.2023.110128_b0515","doi-asserted-by":"crossref","first-page":"4867","DOI":"10.1021\/acs.jmedchem.6b00211","article-title":"The Identification and Pharmacological Characterization of 6-(tert-Butylsulfonyl)-N-(5-fluoro-1H-indazol-3-yl)quinolin-4-amine (GSK583), a Highly Potent and Selective Inhibitor of RIP2 Kinase","volume":"59","author":"Haile","year":"2016","journal-title":"J. Med. Chem."},{"issue":"10","key":"10.1016\/j.intimp.2023.110128_b0520","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1021\/acsmedchemlett.7b00258","article-title":"Identification of Potent and Selective RIPK2 Inhibitors for the Treatment of Inflammatory Diseases","volume":"8","author":"He","year":"2017","journal-title":"ACS Med. Chem. Lett."},{"issue":"2","key":"10.1016\/j.intimp.2023.110128_b0525","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1124\/jpet.117.247163","article-title":"Identification and Characterization of Novel Receptor-Interacting Serine\/Threonine-Protein Kinase 2 Inhibitors Using Structural Similarity Analysis","volume":"365","author":"Salla","year":"2018","journal-title":"J. Pharmacol. Exp. Ther."},{"issue":"14","key":"10.1016\/j.intimp.2023.110128_b0530","doi-asserted-by":"crossref","first-page":"6482","DOI":"10.1021\/acs.jmedchem.9b00575","article-title":"Discovery of a First-in-Class Receptor Interacting Protein 2 (RIP2) Kinase Specific Clinical Candidate, 2-((4-(Benzo[d]thiazol-5-ylamino)-6-(tert-butylsulfonyl)quinazolin-7-yl)oxy)ethyl Dihydrogen Phosphate, for the Treatment of Inflammatory Diseases","volume":"62","author":"Haile","year":"2019","journal-title":"J. Med. Chem."},{"issue":"11","key":"10.1016\/j.intimp.2023.110128_b0535","doi-asserted-by":"crossref","first-page":"1518","DOI":"10.1021\/acsmedchemlett.9b00141","article-title":"Discovery of Pyrazolocarboxamides as Potent and Selective Receptor Interacting Protein 2 (RIP2) Kinase Inhibitors","volume":"10","author":"Haffner","year":"2019","journal-title":"ACS Med. Chem. Lett."},{"issue":"200","key":"10.1016\/j.intimp.2023.110128_b0540","article-title":"Receptor-interacting protein kinase 2 (RIPK2) and nucleotide-binding oligomerization domain (NOD) cell signaling inhibitors based on a 3,5-diphenyl-2-aminopyridine scaffold","volume":"15","author":"Suebsuwong","year":"2020","journal-title":"Eur. J. Med. Chem."},{"issue":"1","key":"10.1016\/j.intimp.2023.110128_b0545","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1038\/s42003-020-0868-6","article-title":"Extended pharmacodynamic responses observed upon PROTAC-mediated degradation of RIPK2","volume":"3","author":"Mares","year":"2020","journal-title":"Communications biology."},{"issue":"17","key":"10.1016\/j.intimp.2023.110128_b0550","doi-asserted-by":"crossref","first-page":"12978","DOI":"10.1021\/acs.jmedchem.1c01118","article-title":"Optimization of a Series of RIPK2 PROTACs","volume":"64","author":"Miah","year":"2021","journal-title":"J. Med. Chem."},{"issue":"215","key":"10.1016\/j.intimp.2023.110128_b0555","article-title":"Design of pyrido[2,3-d]pyrimidin-7-one inhibitors of receptor interacting protein kinase-2 (RIPK2) and nucleotide-binding oligomerization domain (NOD) cell signaling","volume":"5","author":"Nikhar","year":"2021","journal-title":"Eur. J. Med. Chem."}],"container-title":["International Immunopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576923004496?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576923004496?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T17:51:40Z","timestamp":1761587500000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1567576923004496"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5]]},"references-count":111,"alternative-id":["S1567576923004496"],"URL":"https:\/\/doi.org\/10.1016\/j.intimp.2023.110128","relation":{},"ISSN":["1567-5769"],"issn-type":[{"value":"1567-5769","type":"print"}],"subject":[],"published":{"date-parts":[[2023,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"RIPK2 as a promising druggable target for autoimmune diseases","name":"articletitle","label":"Article Title"},{"value":"International Immunopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.intimp.2023.110128","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"110128"}}